Esophagus and regenerative medicine

World Journal of Gastroenterology

Volumn 18, Issue 47, 2012, Pages 6894-6899

  Londono, Ricardo ^a,b   Jobe, Blair A ^b   Hoppo, Toshitaka ^b   Badylak, Stephen F ^a,c,d  

^a MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d PA 15260   (United States)

Author keywords

Biomaterial mediated esophageal repair; Esophageal repair; Extracellular matrix; Extracellular matrix scaffold

Indexed keywords

POLYGLYCOLIC ACID;

ARTICLE; BARRETT ESOPHAGUS; DYSPLASIA; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; EXTRACELLULAR MATRIX; HEALTH CARE QUALITY; HUMAN; INCIDENCE; NONHUMAN; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATION; REGENERATIVE MEDICINE; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 84873895879     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i47.6894     Document Type: Article

References (87)

1. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003; 60: 1342-1350
2. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870
3. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9: 283-289
4. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010; 89: 219-229
5. Adamson R. Role of macrophages in normal wound healing: an overview. J Wound Care 2009; 18: 349-351
6. Halprin KM. Epidermal "turnover time"--a re-examination. Br J Dermatol 1972; 86: 14-19
7. Iizuka H. Epidermal architecture that depends on turnover time. J Dermatol Sci 1995; 10: 220-223
8. Fuchs E. Skin stem cells: rising to the surface. J Cell Biol 2008; 180: 273-284
9. Adolphe C, Wainwright B. Pathways to improving skin regeneration. Expert Rev Mol Med 2005; 7: 1-14
10. Moffatt DJ, Rosse C, Yoffey JM. Identity of the haemopoietic stem cell. Lancet 1967; 2: 547-548
11. Lewis JP, Trobaugh FE. Haematopoietic stem cells. Nature 1964; 204: 589-590
12. Loutit JF. Versatile haemopoietic stem cells. Br J Haematol 1968; 15: 333-336
13. Dunn CD. The differentiation of haemopoietic stem cells. Ser Haematol 1971; 4: 1-71
14. Leblond CP, Clermont Y, Nadler NJ. The pattern of stem cell renewal in three epithelia: (esophagus, intestine and testis). Proc Can Cancer Conf 1967; 7: 3-30
15. Yau HC, Cairnie AB. Cell-survival characteristics of intestinal stem cells and crypts of gamm-irradiated mice. Radiat Res 1979; 80: 92-107
16. Potten CS, Chadwick C, Ijiri K, Tsubouchi S, Hanson WR. The recruitability and cell-cycle state of intestinal stem cells. Int J Cell Cloning 1984; 2: 126-140
17. Morgan TH. Regeneration. New York and London: Macmillan Co., 1901: 170
18. Vracko R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 1974; 77: 314-346
19. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286-300
20. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010; 176: 2-13
21. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-1530
22. Grounds MD. Muscle regeneration: molecular aspects and therapeutic implications. Curr Opin Neurol 1999; 12: 535-543
23. Grogan BF, Hsu JR. Volumetric muscle loss. J Am Acad Orthop Surg 2011; 19 Suppl 1: S35-S37
24. Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV, Ornato JP, Zalenski RJ, Penney J, Tiefenbrunn AJ, Greenland P. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA 2011; 306: 2120-2127
25. Thelle DS. Case fatality of acute myocardial infarction: an emerging gender gap. Eur J Epidemiol 2011; 26: 829-831
26. Allison MA, Hsi S, Wassel CL, Morgan C, Ix JH, Wright CM, Criqui MH. Calcifed atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol 2012; 32: 140-146
27. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215
28. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Com- mittee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-151
29. Millikan CH. Cerebrovascular disease. Science 1966; 152: 803-807
30. Baryan HK, Allan SM, Vail A, Smith CJ. Systematic review and meta-analysis of the efficacy of statins in experimental stroke. Int J Stroke 2012; 7: 150-156
31. Jaffer H, Morris VB, Stewart D, Labhasetwar V. Advances in Stroke Therapy. Drug Deliv Transl Res 2011; 1: 409-419
32. Burns AS, O'Connell C. The challenge of spinal cord injury care in the developing world. J Spinal Cord Med 2012; 35: 3-8
33. Devivo MJ. Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord 2012; 50: 365-372
34. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev 2012; 1: CD001046
35. O'Dowd JK. Basic principles of management for cervical spine trauma. Eur Spine J 2010; 19 Suppl 1: S18-S22
36. Greenbaum CJ. Type 1 diabetes intervention trials: what have we learned? A critical review of selected intervention trials. Clin Immunol 2002; 104: 97-104
37. Allen S, Huber J, Devendra D. Prevalence of organ-specifc autoantibodies in childhood- and adult-onset type 1 diabetes. Ann N Y Acad Sci 2008; 1150: 260-262
38. Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes. Am J Ther 2005; 12: 481-490
39. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ 2004; 328: 750-754
40. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007; 17: 2-9
41. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252
42. Jemal A, Bray F, Center M.M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
43. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg 2001; 25: 196-203
44. Alcantara PS, Spencer-Netto FA, Silva-Júnior JF, Soares LA, Pollara WM, Bevilacqua RG. Gastroesophageal isoperistaltic bypass in the palliation of irresectable thoracic esophageal cancer. Int Surg 1997; 82: 249-253
45. Ellis FH. Standard resection for cancer of the esophagus and cardia. Surg Oncol Clin N Am 1999; 8: 279-294
46. Gawad KA, Hosch SB, Bumann D, Lübeck M, Moneke LC, Bloechle C, Knoefel WT, Busch C, Küchler T, Izbicki JR. How important is the route of reconstruction after esophagectomy: a prospective randomized study. Am J Gastroenterol 1999; 94: 1490-1496
47. Badylak S, Meurling S, Chen M, Spievack A, Simmons-Byrd A. Resorbable bioscaffold for esophageal repair in a dog model. J Pediatr Surg 2000; 35: 1097-1103
48. Haight C. Some observations on esophageal atresias and tracheoesophageal fistulas of congenital origin. J Thorac Surg 1957; 34: 141-172
49. Katzka DA. Caustic Injury to the Esophagus. Curr Treat Options Gastroenterol 2001; 4: 59-66
50. Luostarinen M, Isolauri J. Esophageal perforation and caustic injury: approach to instrumental perforations of the esophagus. Dis Esophagus 1997; 10: 86-89
51. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103: 714-736
52. Collard JM. High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clin N Am 2002; 12: 77-92
53. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett' s esophagus with high-grade dysplasia. Gastrointest Endosc 1999; 49: 170-176
54. Rice TW, Zuccaro G, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998; 65: 787-792
55. Keeley SB, Pennathur A, Gooding W, Landreneau RJ, Christie NA, Luketich J. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol 2007; 14: 2406-2410
56. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
57. Dumot JA, Vargo JJ, Falk GW, Frey L, Lopez R, Rice TW. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 2009; 70: 635-644
58. May A, Gossner L, Behrens A, Kohnen R, Vieth M, Stolte M, Ell C. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003; 58: 167-175
59. Yamamoto H. Technology insight: endoscopic submucosal dissection of gastrointestinal neoplasms. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 511-520
60. Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ, Pleskow DK, Chuttani R, Reymunde A, Santiago N, Chang KJ, Kimmey MB, Fleischer DE. Balloon- based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65: 185-195
61. Croagh D, Phillips WA, Redvers R, Thomas RJ, Kaur P. Identification of candidate murine esophageal stem cells using a combination of cell kinetic studies and cell surface markers. Stem Cells 2007; 25: 313-318
62. Croagh D, Thomas RJ, Phillips WA, Kaur P. Esophageal stem cells--a review of their identification and characterization. Stem Cell Rev 2008; 4: 261-268
63. Seery JP. Stem cells of the oesophageal epithelium. J Cell Sci 2002; 115: 1783-1789
64. Seery JP, Watt FM. Asymmetric stem-cell divisions defne the architecture of human oesophageal epithelium. Curr Biol 2000; 10: 1447-1450
65. Souza RF, Schwartz RE, Mashimo H. Esophageal stem cells and 3D-cell culture models. Ann N Y Acad Sci 2011; 1232: 316-322
66. Takagi R, Murakami D, Kondo M, Ohki T, Sasaki R, Mizutani M, Yamato M, Nishida K, Namiki H, Yamamoto M, Okano T. Fabrication of human oral mucosal epithelial cell sheets for treatment of esophageal ulceration by endoscopic submucosal dissection. Gastrointest Endosc 2010; 72: 1253-1259
67. Ohki T, Yamato M, Murakami D, Takagi R, Yang J, Namiki H, Okano T, Takasaki K. Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 2006; 55: 1704-1710
68. Takagi R, Yamato M, Murakami D, Kondo M, Ohki T, Sasaki R, Nishida K, Namiki H, Yamamoto M, Okano T. Fabrication and validation of autologous human oral mucosal epithelial cell sheets to prevent stenosis after esophageal endoscopic submucosal dissection. Pathobiology 2011; 78: 311-319
69. Badylak SF, Vorp DA, Spievack AR, Simmons-Byrd A, Hanke J, Freytes DO, Thapa A, Gilbert TW, Nieponice A. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 2005; 128: 87-97
70. Nieponice A, McGrath K, Qureshi I, Beckman EJ, Luketich JD, Gilbert TW, Badylak SF. An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 2009; 69: 289-296
71. Nieponice A, Gilbert TW, Badylak SF. Reinforcement of esophageal anastomoses with an extracellular matrix scaf- fold in a canine model. Ann Thorac Surg 2006; 82: 2050-2058
72. Badylak SF, Hoppo T, Nieponice A, Gilbert TW, Davison JM, Jobe BA. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 2011; 17: 1643-1650
73. Grikscheit T, Ochoa ER, Srinivasan A, Gaissert H, Vacanti JP. Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg 2003; 126: 537-544
74. Marzaro M, Vigolo S, Oselladore B, Conconi MT, Ribatti D, Giuliani S, Nico B, Perrino G, Nussdorfer GG, Parnigotto PP. In vitro and in vivo proposal of an artifcial esophagus. J Biomed Mater Res A 2006; 77: 795-801
75. Nakase Y, Nakamura T, Kin S, Nakashima S, Yoshikawa T, Kuriu Y, Sakakura C, Yamagishi H, Hamuro J, Ikada Y, Otsuji E, Hagiwara A. Intrathoracic esophageal replacement by in situ tissue-engineered esophagus. J Thorac Cardiovasc Surg 2008; 136: 850-859
76. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997; 67: 478-491
77. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol 2008; 20: 109-116
78. Gilbert TW, Stewart-Akers AM, Badylak SF. A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 2007; 28: 147-150
79. Record RD, Hillegonds D, Simmons C, Tullius R, Rickey FA, Elmore D, Badylak SF. In vivo degradation of 14C- labeled small intestinal submucosa (SIS) when used for uri- nary bladder repair. Biomaterials 2001; 22: 2653-2659
80. Badylak S, Kokini K, Tullius B, Whitson B. Strength over time of a resorbable bioscaffold for body wall repair in a dog model. J Surg Res 2001; 99: 282-287
81. Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, Heber-Katz E, Bedelbaeva K, McIntosh D, Dewilde A, Braunhut SJ, Badylak SF. Degradation products of extracel- lular matrix affect cell migration and proliferation. Tissue Eng Part A 2009; 15: 605-614
82. Beattie AJ, Gilbert TW, Guyot JP, Yates AJ, Badylak SF. Chemoattraction of progenitor cells by remodeling extracel- lular matrix scaffolds. Tissue Eng Part A 2009; 15: 1119-1125
83. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313
84. Agrawal V, Tottey S, Johnson SA, Freund JM, Siu BF, Badylak SF. Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputa- tion. Tissue Eng Part A 2011; 17: 2435-2443
85. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008; 14: 1835-1842
86. Brown BN, Londono R, Tottey S, Zhang L, Kukla KA, Wolf MT, Daly KA, Reing JE, Badylak SF. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater 2012; 8: 978-987
87. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009; 30: 1482-1491